Zobrazeno 1 - 10
of 315
pro vyhledávání: '"Russell E. Lewis"'
Autor:
Russell E. Lewis, Marta Palombo, Erica Diani, Benedetta Secci, Davide Gibellini, Paolo Gaibani
Publikováno v:
Cells, Vol 13, Iss 16, p 1315 (2024)
We investigated the activity of cefiderocol/β-lactamase inhibitor combinations against clinical strains with different susceptibility profiles to cefiderocol to explore the potentiality of antibiotic combinations as a strategy to contain the major p
Externí odkaz:
https://doaj.org/article/0af9bc8691ac48acaea1a559592b899f
Autor:
Russell E. Lewis
Publikováno v:
Journal of Fungi, Vol 10, Iss 6, p 382 (2024)
Dimitrios P [...]
Externí odkaz:
https://doaj.org/article/80a3a52dc1cd4892b3de755e3d34d486
Autor:
Paolo Gaibani, Elisa Viciani, Michele Bartoletti, Russell E. Lewis, Tommaso Tonetti, Donatella Lombardo, Andrea Castagnetti, Federica Bovo, Clara Solera Horna, Marco Ranieri, Pierluigi Viale, Maria Carla Re, Simone Ambretti
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract COVID-19 infection may predispose to secondary bacterial infection which is associated with poor clinical outcome especially among critically ill patients. We aimed to characterize the lower respiratory tract bacterial microbiome of COVID-19
Externí odkaz:
https://doaj.org/article/e865db79ecc6435cb50c8af93034831e
Autor:
Sarah Parisi, Loredana Ruggeri, Elisa Dan, Simonetta Rizzi, Barbara Sinigaglia, Darina Ocadlikova, Andrea Bontadini, Valeria Giudice, Elena Urbani, Sara Ciardelli, Chiara Sartor, Gianluca Cristiano, Jacopo Nanni, Letizia Zannoni, Gabriella Chirumbolo, Mario Arpinati, Russell E. Lewis, Francesca Bonifazi, Giovanni Marconi, Giovanni Martinelli, Cristina Papayannidis, Stefania Paolini, Andrea Velardi, Michele Cavo, Roberto M. Lemoli, Antonio Curti
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
Recently, many reports were published supporting the clinical use of adoptively transferred natural killer (NK) cells as a therapeutic tool against cancer, including acute myeloid leukemia (AML). Our group demonstrated promising clinical response usi
Externí odkaz:
https://doaj.org/article/b1357030d2eb430392dd08af0036318e
Autor:
Sebastian Wurster, Pappanaicken R. Kumaresan, Nathaniel D. Albert, Paul J. Hauser, Russell E. Lewis, Dimitrios P. Kontoyiannis
Publikováno v:
mBio, Vol 10, Iss 3 (2019)
ABSTRACT Efficient live-imaging methods are pivotal to understand fungal morphogenesis, especially as it relates to interactions with host immune cells and mechanisms of antifungal drugs. Due to the notable similarities in growth patterns of neuronal
Externí odkaz:
https://doaj.org/article/5c45886b39dc445e83d10220e83ba0c0
Autor:
Tamara Zoran, Bettina Sartori, Laura Sappl, Maria Aigner, Ferran Sánchez-Reus, Antonio Rezusta, Anuradha Chowdhary, Saad J. Taj-Aldeen, Maiken C. Arendrup, Salvatore Oliveri, Dimitrios P. Kontoyiannis, Ana Alastruey-Izquierdo, Katrien Lagrou, Giuliana Lo Cascio, Jacques F. Meis, Walter Buzina, Claudio Farina, Miranda Drogari-Apiranthitou, Anna Grancini, Anna M. Tortorano, Birgit Willinger, Axel Hamprecht, Elizabeth Johnson, Lena Klingspor, Valentina Arsic-Arsenijevic, Oliver A. Cornely, Joseph Meletiadis, Wolfgang Prammer, Vivian Tullio, Jörg-Janne Vehreschild, Laura Trovato, Russell E. Lewis, Esther Segal, Peter-Michael Rath, Petr Hamal, Manuel Rodriguez-Iglesias, Emmanuel Roilides, Sevtap Arikan-Akdagli, Arunaloke Chakrabarti, Arnaldo L. Colombo, Mariana S. Fernández, M. Teresa Martin-Gomez, Hamid Badali, Georgios Petrikkos, Nikolai Klimko, Sebastian M. Heimann, Omrum Uzun, Maryam Roudbary, Sonia de la Fuente, Jos Houbraken, Brigitte Risslegger, Raquel Sabino, Cornelia Lass-Flörl, Michaela Lackner
Publikováno v:
Frontiers in Microbiology, Vol 9 (2019)
Externí odkaz:
https://doaj.org/article/6494b983de1b43c394dcf41f161be6e4
Autor:
Paolo Gaibani, Russell E. Lewis, Silvia L. Volpe, Maddalena Giannella, Caterina Campoli, Maria Paola Landini, PierLuigi Viale, Maria Carla Re, Simone Ambretti
Publikováno v:
International Journal of Infectious Diseases, Vol 65, Iss , Pp 1-3 (2017)
Objectives: Combination therapy has been recommended when using ceftazidimeâavibactam (CAZâAVI) for the treatment of KPC-producing Klebsiella pneumoniae (KPC-Kp), but the optimal combination is unknown. Six common antimicrobial agents (ertapenem, i
Externí odkaz:
https://doaj.org/article/fbae3b803e8d426c8a62106b8a3a132d
Autor:
Dierdre B. Axell-House, Sebastian Wurster, Ying Jiang, Andreas Kyvernitakis, Russell E. Lewis, Jeffrey J. Tarrand, Issam I. Raad, Dimitrios P. Kontoyiannis
Publikováno v:
Journal of Fungi, Vol 7, Iss 3, p 217 (2021)
Although breakthrough mucormycosis (BT-MCR) is known to develop on mold-active antifungals without Mucorales activity, it can also occur while on Mucorales-active antifungals. Herein, we retrospectively compared the characteristics and outcomes of pa
Externí odkaz:
https://doaj.org/article/69b0faadcac14db8a99dafe39b76bd22
Autor:
Paolo E. Coppola, Paolo Gaibani, Chiara Sartor, Simone Ambretti, Russell E. Lewis, Claudia Sassi, Marco Pignatti, Stefania Paolini, Antonio Curti, Fausto Castagnetti, Margherita Ursi, Michele Cavo, Marta Stanzani
Publikováno v:
Microorganisms, Vol 8, Iss 12, p 2055 (2020)
The effectiveness of ceftolozane/tazobactam for the treatment of infections in neutropenic patients caused by hypervirulent multidrug-resistant (MDR) Pseudomonas aeruginosa has not been previously reported. We identified seven cases of MDR P. aerugin
Externí odkaz:
https://doaj.org/article/164dbb63f6dd4e5d99ff8e9a9827c434
Publikováno v:
Journal of Fungi, Vol 7, Iss 1, p 17 (2020)
Invasive fungal infections (IFIs) are associated with high mortality rates and timely appropriate antifungal therapy is essential for good outcomes. Emerging antifungal resistance among Candida and Aspergillus spp., the major causes of IFI, is concer
Externí odkaz:
https://doaj.org/article/e822c0ff0e7944de91c93d8ae938e708